Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urinary Bladder Neoplasms 18Non-Muscle Invasive Bladder Neoplasms 12Carcinoma, Transitional Cell 11Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Anus Neoplasms 5Lung Neoplasms 4Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Urologic Neoplasms 2Urologic Diseases 2Urogenital Neoplasms 2Urinary Bladder Diseases 2Stomach Neoplasms 2Neoplasms by Site 2Colonic Neoplasms 2Anal Canal Carcinoma 2Uterine Cervical Neoplasms 1Urogenital Diseases 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Neoplasms, Squamous Cell 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mycobacterium Infections 1

Interventions

pegaspargase 2Methylprednisolone 2Etoposide 2spartalizumab 1Tegafur 1Mitomycin 1Lenalidomide 1Epirubicin 1Doxorubicin 1Dexamethasone 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Epstein-Barr Virus Infections × Mitomycin × Clear all
NCT02363400 2025-08-19

A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

National Health Research Institutes, Taiwan

Phase 3 Terminated
10 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡